17β-Estradiol Induces Overproliferation in Adenomyotic Human Uterine Smooth Muscle Cells of the Junctional Zone Through Hyperactivation of the Estrogen Receptor-Enhanced RhoA/ROCK Signaling Pathway
17β-estradiol induces overproliferation in adenomyotic uterine smooth muscle cells via estrogen receptor-enhanced RhoA/ROCK signaling, leading to cell cycle alterations.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This study examined how 17β-estradiol (E2) affects proliferation-related signaling in human uterine smooth muscle cells (SMCs) from the junctional zone, comparing adenomyosis (ADS) cells with non-ADS cells. The authors found that E2 increased expression and hyperactivation of estrogen receptor (ER)-dependent RhoA and its downstream effectors ROCK1 and ROCK2, and this signaling was linked to overproliferation in ADS JZ SMCs, accompanied by downregulation of cyclin-dependent kinase inhibitors (p21Waf1/Cip1 and p27Kip1) and upregulation of multiple CDKs and cyclins. A key caveat is that the work is based on in vitro treatment of isolated cells rather than in vivo demonstration of causality. This paper is centrally about adenomyosis—specifically, it tests how ER-enhanced RhoA/ROCK signaling mediates E2-induced overproliferation in adenomyotic human uterine junctional zone smooth muscle cells.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (37)
- Adenomyosis: Review of the Literature via openalex
- Clinical effects of the levonorgestrel-releasing intrauterine device in patients with adenomyosis via openalex
- Estrogen and progesterone receptor isoform distribution through the menstrual cycle in uteri with and without adenomyosis via openalex
- [Expression of ERα in endometrial-myometria interface of human adenomyosis]. via openalex
- [Expression of RhoA and Rho kinase in junctional zone of human adenomyosis and its relationship with dysmenorrheal]. via openalex
- Fasudil Inhibits the Proliferation and Contractility and Induces Cell Cycle Arrest and Apoptosis of Human Endometriotic Stromal Cells: A Promising Agent for the Treatment of Endometriosis via openalex
- Is adenomyosis the neglected phenotype of an endomyometrial dysfunction syndrome? via openalex
- Medical and surgical management of adenomyosis via openalex
- MRI Characteristics of the Uterine Junctional Zone: From Normal to the Diagnosis of Adenomyosis via openalex
- Promoter Hypermethylation of Progesterone Receptor Isoform B (PR-B) in Adenomyosis and Its Rectification by a Histone Deacetylase Inhibitor and a Demethylation Agent via openalex
- Surgical and medical treatment of adenomyosis via openalex
- The elusive adenomyosis of the uterus—revisited via openalex
- The place of dydrogesterone in the treatment of endometriosis and adenomyosis via openalex
- W2082649057 via openalex
- W2085593164 via openalex
- W2096117281 via openalex
- W2098902378 via openalex
- W2104235456 via openalex
- W2123412259 via openalex
- W2138240434 via openalex
- W2141091145 via openalex
- W2155109817 via openalex
- W2155635998 via openalex
- W2165703156 via openalex
- W2073190445 via openalex
- W1981756718 via openalex
- W2006020820 via openalex
- W2013576879 via openalex
- W2020803716 via openalex
- W2033232788 via openalex
- W2038214146 via openalex
- W2040770590 via openalex
- W2046867627 via openalex
- W2050549532 via openalex
- W2054264645 via openalex
- W2070657240 via openalex
- W1562863690 via openalex
Cited by (12)
- Research Progress of Traditional Chinese Medicine in the Treatment of Adenomyosis-Related Signaling Pathways 2026
- The interaction between inflammation and estrogen in adenomyosis : from molecular mechanisms to therapeutic strategies 2026
- Archimetra: imaging aspects of combined pathology of the endometrium and myometrium 2023
- Insights on Adenomyosis Development 2022
- Uterine Anteroposterior Diameter Measured by Transvaginal Sonography is a Predictor for Dysmenorrhea in Patients With and Without Endometriosis 2022
- Upregulated Talin1 synergistically boosts β-estradiol-induced proliferation and pro-angiogenesis of eutopic and ectopic endometrial stromal cells in adenomyosis 2021
- Androgens, oestrogens and endometrium: a fine balance between perfection and pathology 2020
- Mechanisms Underlying Adenomyosis-Related Fibrogenesis 2019
- Expression of Cannabinoid Receptors in Myometrium and its Correlation With Dysmenorrhea in Adenomyosis 2019
- RhoA/ROCK/ARHGAP26 signaling in the eutopic and ectopic endometrium is involved in clinical characteristics of adenomyosis 2018
- Comparative systems genetics view of endometriosis and uterine leiomyoma: Two sides of the same coin? 2016
- What are the most reliable signs for the radiologic diagnosis of uterine adenomyosis? An ultrasound and MRI prospective 2015
Source provenance
- europepmc
- last seen: 2026-06-12T06:13:51.797165+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:17:52.213533+00:00